RUPAFIN

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Singapore, Turkey

Active ingredients

The drug RUPAFIN contains one active pharmaceutical ingredient (API):

1 Rupatadine UNII XJ6OT32M93 - RUPATADINE FUMARATE

Rupatadine is a second-generation antihistamine, long-acting histamine antagonist, with selective peripheral H1-receptor antagonist activity. Some of the metabolites (desloratadine and its hydroxylated metabolites) retain an antihistaminic activity and may partially contribute to the overall efficacy of the drug. Read about Rupatadine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RUPAFIN Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AX28	Rupatadine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX28

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 552919110082817, 552919110082917
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00114666, 02833951, 05454705, 08922472, 08922584, 08922590, 09534660, 09534677, 09534683, 12448898, 12600917, 12600923, 12600952, 12653351, 12653368, 12653374
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4330-MEE-0818, 4423-MEE-1018
Country: EE	Ravimiamet	Identifier(s): 1269952, 1269963, 1269974, 1269985, 1269996, 1270000, 1270011, 1270022, 1505629
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64053, 75666, BE272045
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8535, 9165
Country: IT	Agenzia del Farmaco	Identifier(s): 037880061, 037880097
Country: JP	医薬品医療機器総合機構	Identifier(s): 4490034F1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1023883, 1031086, 1031087, 1031088, 1031089, 1031090, 1031091, 1031092, 1058086, 1082389, 1082884, 1087156
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 102415, 98426
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100182363, 100281987, 100385712, 100400110, 100410485, 100413590, 100413845, 100415608, 100418481, 100422904, 100434534, 100435189, 100448654
Country: SG	Health Sciences Authority	Identifier(s): 14087P, 14868P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514017523, 8699514590163